Biotoxtech Co., Ltd. (KOSDAQ:086040)

Market Cap	32.38B -33.1%
Revenue (ttm)	47.64B +9.3%
Net Income	769.13M
EPS	49.48
Shares Out	15.72M
PE Ratio	41.63
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,318
Open	1,904.00
Previous Close	2,010.00
Day's Range	1,904.00 - 2,090.00
52-Week Range	1,896.00 - 4,115.00
Beta	0.45
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Biotoxtech

Biotoxtech Co., Ltd. engages in the safety evaluation of synthetic medicines, biomedicines, cell therapy products, gene therapy products, health functional foods, chemicals, and pesticides in South Korea. It is involved in testing and substance screening, clinical pathology and histopathology work, and consulting and government affairs related to non-clinical trials, as well as new drug development. The company’s safety evaluation research field includes general toxicity test, carcinogenicity studies, local toxicity studies, reproductive and de...

• Industry: Medical Laboratories
• Founded: 2000
• Employees: 188
• Stock Exchange: KOSDAQ
• Ticker Symbol: 086040

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 21, 2026

Data Sources Report a data error